Skip to main content
OpenTrials

Clinical trial condition

Stage IIIC Melanoma

Explore clinical trials studying Stage IIIC Melanoma. Study availability and eligibility vary by location and protocol.

11 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Stage IIIC Melanoma trial results

Completed

Trametinib in Treating Patients With Advanced Melanoma With BRAF Non-V600 Mutations

NCT02296112

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +13 more
Locations
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States
  • M D Anderson Cancer Center Houston, Texas, United States
View Trial Details
Completed

Molecularly Targeted Therapy in Treating Patients With BRAF Wild-type Melanoma That is Metastatic

NCT02094872

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +14 more
Locations
  • Mayo Clinic Cancer Center Scottsdale, Arizona, United States
  • Smilow Cancer Hospital at Yale-New Haven New Haven, Connecticut, United States
  • Mayo Clinic Cancer Center Jacksonville, Florida, United States
  • University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
View Trial Details
Completed

Imatinib Mesylate in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery

NCT00470470

Conditions
Acral Lentiginous Malignant Melanoma, Melanoma, Neoplasms, +15 more
Locations
  • University of California at Los Angeles (UCLA ) Los Angeles, California, United States
  • Mount Sinai Medical Center CCOP Miami Beach, Florida, United States
  • Good Samaritan Medical Center West Palm Beach, Florida, United States
  • Palm Beach Cancer Institute-Main Office West Palm Beach, Florida, United States
View Trial Details

Related conditions